SCHEMBL29566842

SCHEMBL29566842

CCc1c(Cl)nc(N)nc1Oc1ccccc1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 5/20 0.46
▸ HPGD P15428 3/20 0.46
▸ ALDH1A1 P00352 2/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ CYP2C9 P11712 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ KDM4E B2RXH2 2/20 0.40
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ SLC2A1 P11166 1/20 0.39
▸ HSP90AA1 P07900 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ HEXA P06865 1/20 0.38
▸ HEXB P07686 1/20 0.38
▸ MAP4K4 O95819 1/20 0.36
▸ PTGS2 P35354 1/20 0.36
▸ DHFR P00374 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309334 1.00 SMN1; SMN2 (0.46) SMN1; SMN2HPGDALDH1A1CYP1A2CYP2C9
SCHEMBL24309782 0.81 ADORA2A (0.47) SMN1; SMN2HPGDALDH1A1CYP1A2CYP2C9
SCHEMBL24309881 0.74 ADORA2A (0.51) SMN1; SMN2HPGDKDM4EHSP90AA1NPSR1
SCHEMBL24331481 0.73 HEXA (0.41) SMN1; SMN2HPGDALDH1A1CYP1A2CYP2C9
SCHEMBL29515334 0.73 HEXA (0.41) SMN1; SMN2HPGDALDH1A1CYP1A2CYP2C9
SCHEMBL16462552 0.72 SMN1; SMN2 (0.53) SMN1; SMN2HPGDALDH1A1CYP1A2CYP2C9
SCHEMBL12495474 0.70 SMN1; SMN2 (0.46) SMN1; SMN2HPGDALDH1A1CYP1A2CYP2C9
SCHEMBL11154581 0.69 ADORA2A (0.47) SMN1; SMN2HPGDALDH1A1KDM4EHSP90AA1
SCHEMBL3458103 0.67 NPSR1 (0.50) SMN1; SMN2HPGDALDH1A1CYP1A2CYP2C9
Propane SCHEMBL28061941 0.66 TSHR (0.58) SMN1; SMN2HPGDALDH1A1CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback